FIVE STAR BANCORP
FIVE STAR BANCORP Q3 FY2024 earnings call
October 29, 2024 · fiscal period ended 2024-09
EPS · actual vs est
Revenue · actual vs est
Summary
Generated 2024-10-29
Management highlights
- Organic Growth: Successfully opened a whole service office in San Francisco’s Financial District, added 5 seasoned professionals, and saw non-wholesale deposits increase by $92.9 million.
- Underwriting and Expenses: Conservatively underwrote with a 50% loan-to-value on commercial real estate, maintained a 43.37% efficiency ratio.
- Dividend: Declared a $0.20 per share cash dividend, expected to be paid November 12, 2024.
- Loan Portfolio: Loans held for investment increased by $194.3 million, pipeline remains solid, with expected mid-single-digit loan growth in Q4.
- Deposits: Non-interest-bearing deposits as a percent of total deposits increased to 26.67%, with deposit relationships over $5 million accounting for 60.58% of total deposits.
- Capital: Well capitalized, with common equity Tier 1 ratio decreasing from 11.27% to 10.93% between June 30, 2024, and September 30, 2024.
Segment performance
Loans: Loans held for investment increased by $194.3 million (5.95%) during the quarter, with loan originations at $333.8 million, and payoffs/pay-downs at $40.7 million and $98.8 million respectively. Nonperforming loans decreased to 0.05% of loans held for investment. Deposits: Deposits increased by $250.3 million (7.95%), with non-wholesale deposits up $92.9 million and wholesale deposits up $157.4 million. Non-interest-bearing deposits as a percent of total deposits rose to 26.67%. Income Metrics: Net income for the quarter was $10.9 million. Return on average assets was 1.18%, and return on average equity was 11.31%. Average loan yield was 5.98% (up 15 basis points from prior quarter), net interest margin was 3.37% (down 2 basis points from prior quarter).
Guidance
- Loan Growth: Expect mid-single-digit loan growth in the fourth quarter.
- Purchase Strategy: Loans purchased from Bankers Health Group (BHG) capped at $300 million; Q4 expected to see some increase but then steady at $300 million.
- Dividend: Board declared a $0.20 per share cash dividend, payable November 12, 2024, to shareholders of record November 4, 2024.
Risks
- Forward-looking statements involve risks and uncertainties; for a complete discussion, refer to the company’s annual report on Form 10-K for the year ended December 31, 2023, and quarterly reports on Form 10-Q for the 3 months ended March 31, 2024, and June 30, 2024, particularly Item 1A, Risk Factors.
Q&A highlights
Q: Non-interest-bearing deposit growth granularity and future expectations?
A: One relationship accounted for ~20% of the increase, with the rest granular; expect Q4 increases, though not to Q3 extent but noticeable.
Q: Loan purchase strategy and pipeline?
A: BHG loans capped at $300 million; Q4 expected to have some increase, then steady at $300 million; loan growth in Q4 expected to be mid-single-digit.
Q: NIM and CD costs?
A: CDs reprice expected to cause rate decline; marginal loan yield for BHG purchases was 8.11% weighted average.
Q: Bay Area talent and pipeline?
A: Hiring pipeline good, attracting high-quality talent from various banks, with three biz dev candidates and others in pipeline.
Q: Deposit growth mix and churn?
A: Non-interest-bearing deposits from new relationship onboarding; no notable churn in non-wholesale interest-bearing deposits.
Key numbers
Reported versus consensus
Earnings calendar feed
| Metric | Reported | Consensus | Delta | Prior year |
|---|---|---|---|---|
| EPS | — | — | — | — |
| Revenue | — | — | — | — |
Transcript
October 29, 2024Full transcript unavailable for redistribution
The structured summary above covers the available call sections. Full transcript text is not included on this page.
Continue exploring
Prior quarters
This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.